Clinical and polysomnographic analysis of sleep disorders in Parkinson's disease from Brazilian Amazon
Abstract
Background: Sleep disorders affect over eighty percent of patients with Parkinson's disease, significantly impairing their quality of life. Common conditions include obstructive sleep apnea, rapid eye movement sleep behavior disorder, and restless legs syndrome. Investigating the correlation between these disorders and clinical, psychiatric, or motor symptoms is essential to optimize disease management and understand their full impact on patients. Objective: To determine the prevalence of sleep disorders and analyze their clinical, psychiatric, and polysomnographic (PSG) associations in patients with Parkinson's disease from the Amazon region. Methods: An observational cross-sectional study was conducted in a neurology outpatient clinic and sleep laboratory of a public hospital in Manaus, Amazonas. The study was approved by the local Research Ethics Committee under CAAE No. 58684622.2.0000.0007. Adult patients diagnosed with Parkinson's disease (Hoehn and Yahr stages one to three) were included. Patients with dementia, atypical parkinsonism, language disorders, or advanced-stage disease were excluded. Participants underwent a comprehensive neurological evaluation using structured questionnaires, motor assessment through the Unified Parkinson's Disease Rating Scale part three (MDS-UPDRS), and overnight type one PSG. Sleep staging was performed according to the criteria of the American Academy of Sleep Medicine (AASM) by blinded experts. Results: Forty-eight patients were evaluated clinically, with thirty-three undergoing full PSG. The most prevalent sleep disorders identified were obstructive sleep apnea (48%), rapid eye movement sleep behavior disorder (46%), primary snoring (42%), and restless legs syndrome (39.6%). Patients with restless legs syndrome demonstrated significantly higher anxiety symptoms (89.5% versus 55.2%; p=0.01), poorer sleep quality (p=0.006), and greater motor impairment (p=0.02) compared to those without the syndrome. Furthermore, poorer overall subjective sleep quality was significantly associated with depressive mood symptoms (p=0.0331). However, no statistically significant associations were found between the broader presence of sleep disorders and specific motor symptoms such as tremor, gait, or spontaneity. Conclusion: Sleep disorders are highly prevalent in Parkinson's disease. While overall subjective sleep quality is closely linked to depressive mood, the specific presence of restless legs syndrome is strongly associated with increased anxiety and greater motor impairment. Furthermore, these findings provide a pioneering overview of sleep disorders in Parkinson's disease within the Amazonian context, addressing a significant regional data gap and highlighting the importance of systematic polysomnographic screening in clinical practice.